View the week's key company earnings schedule and key stories to watch.
View the week's key company earnings schedule and key stories to watch.The top 5 stories to look out for (28 March - 3 April 2016)
1. TUE 29 MAR Will sugar levy be a bitter pill to swallow for Irn Bru-maker AG Barr? Can AG Barr provide guidance on the possible impact of the sugar levy? How will the company combat any impact on prices when it reports full-year earnings this week? 2. TUE 29 MAR Not so smooth sailing for Carnival Corp? Worries about increased terrorist activity and the Zika virus could impact this week’s Q1 trading update for cruise line operator Carnival Corp. 3. THU 31 MAR Will final UK GDP come in higher than the last revision? A reading higher than the 0.5% quarter-on-quarter rise in the last revision would be good for Chancellor Osborne, who had a problematic Budget due to the economic slowdown. 4. FRI 1 APR Will March’s non-farm payrolls paint a mixed jobs picture? Another weak wages number after February’s sharp drop could push expectations for a US rate rise further out into the middle of the year.
5. FRI 1 APR Further weakness in Chinese manufacturing could spell bad news for markets Could a reading below 48 in this week’s Caixin Chinese PMI data trigger a sell-off in the markets?
Key company earnings (28 March - 3 April)
Monday Cal-Maine Foods (US) – Q3
Tuesday AG Barr (UK) - full-year Carnival (US) - Q1 Conn's (US) – Q4 Lennar (US) – Q1 Sonic (US) – Q2
Wednesday BowLeven (UK) - half-year Micron Technology (US) - Q2
Thursday Chesnara (UK) - full-year Hilton Food (UK) - full-year James Halstead (UK) - half-year Polypipe UK) - full-year Wireless (UK) - full-year
Friday No major companies scheduled to report
Company announcements are subject to change. All the events listed above were correct at the time of writing.
CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.